The role of IκBα in TNF-α-induced apoptosis in hepatic stellate cell line HSC-T6

Abstract

To investigate the role of NF-κB in TNF-α induced apoptosis in HSC-T6, a mutant IκBα was transfected into HSC-T6 cells by lipofectin transfection technique and its transient effect was examined 48 h after the transfection. The activation of NF-κB was detected by immune fluorescence cytochemistry and Western blotting with anti-p65 antibody. The apoptosis and the rate of inhibition by TNF-α in both transfected and untransfected HSC-T6 cells were measured respectively by FAC-Scan side scatter analysis and MTT methods. Our results showed that TNF-α could activate NF-κB in untransfected cells but not in transfected HSC-T6 cells. The percentage of apoptosis in transfected cells were significantly higher than that in the untransfected ones (P<0.01) and it was also true of the inhibition rate (P<0.01). It is concluded that the resistance of HSC-T6 towards apoptosis induced by TNF-α can be mediated by NF-κB activation. The inhibition of NF-κB activation by mutant IκBα can attenuate the resistance of HSC-T6 cells and increase its sensitivity to TNF-α.

Keywords

nuclear factor-κB / nuclear factor inhibiting protein / tumor necrosis factor-α / hepatic stellate cells / apoptosis

References

[1] SenR., BaltimoreD.. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986, 46: 705-716

[2] ChenF., CastranovaV., ShiX.. New insights into the role of nuclear factor—kappa B in cell growth regulation. Am J Pathol, 2001, 159: 387-397

[3] LiQ., VermaI.M.. NF-κB regulation in the immune system. Nat Rev Immunol, 2002, 2: 725-734

[4] BoursV., Bentires-AljM., HellinA. C., et al.. Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol, 2000, 60: 1085-1089

[5] LeeK. S.. Hepatic fibrogenesis. Korean J Gastroenterol, 2006, 48: 297-305

[6] MiyamotoS., VermaI. M.. Rel/NF-kappa B/I kappa B story. Adv Cancer Res, 1995, 66: 255-292

[7] LiX., StarkG. R.. NF-κB-dependent signaling pathways. Exp Hematol, 2002, 30: 285-296

[8] BolandM. P., FosterS. J., ONeillL. A. J.. Daunorubicin activates NF-κB and induces kB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J Biol Chem, 1997, 272: 12 952-12 960

[9] DasK. C., WhiteC. W.. Activation of NF-κB by antineoplastic agents. J Biol Chem, 1997, 272: 14 914-14 920

[10] HusH., ShuH. B., PanM. G., et al.. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 1996, 84: 299-308

[11] BrockmanJ. A., SchererD. C., McKinseyT. A., et al.. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-κB activation. Mol Cell Biol, 1995, 15: 2 809-2 818

[12] ChenC. G., MalliarosJ., KaterelosM., et al.. Inhibition of NF-κB activation by a dominant-negative mutant of I kappaB alpha. Mol Immunol, 1996, 33: 57-61

[13] WangC. Y., MayoM. W., BaldwinA. S.. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 1996, 274: 784-787

[14] Van AntwerpD. J., MartinS. J., KafriT., et al.. Suppression of TNF-α-induced apoptosis by NF-κB. Science, 1996, 274: 787-789

[15] FriedmanS. L.. The virtuosity of hepatic stellate cells. Gastroenterology, 1999, 117: 1244-1246

[16] TsukadaS., ParsonsC. J., RippeR. A.. Mechanisms of liver fibrosis. Clin Chim Acta, 2006, 364: 33-60

[17] LimuroY., NishiuraT., HellerbrandC., et al.. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest, 1998, 101: 802-811